203 related articles for article (PubMed ID: 33105471)
1. Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions.
Shelton EM; Reeves DB; Bender Ignacio RA
AIDS Rev; 2020 Oct; 23(1):28-39. PubMed ID: 33105471
[TBL] [Abstract][Full Text] [Related]
2. Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA.
Strongin Z; Sharaf R; VanBelzen DJ; Jacobson JM; Connick E; Volberding P; Skiest DJ; Gandhi RT; Kuritzkes DR; O'Doherty U; Li JZ
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593048
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption.
Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M
mBio; 2021 Feb; 12(1):. PubMed ID: 33622719
[TBL] [Abstract][Full Text] [Related]
4. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.
Li JZ; Etemad B; Ahmed H; Aga E; Bosch RJ; Mellors JW; Kuritzkes DR; Lederman MM; Para M; Gandhi RT
AIDS; 2016 Jan; 30(3):343-53. PubMed ID: 26588174
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
[TBL] [Abstract][Full Text] [Related]
6. Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
Hellmuth J; Muccini C; Colby DJ; Kroon E; de Souza M; Crowell TA; Chan P; Sacdalan C; Intasan J; Benjapornpong K; Tipsuk S; Puttamaswin S; Chomchey N; Valcour V; Sarnecki M; Tomaka F; Krebs SJ; Slike BM; Jagodzinski LL; Dumrongpisutikul N; Sailasuta N; Samboju V; Michael NL; Robb ML; Vasan S; Ananworanich J; Phanuphak P; Phanuphak N; Paul R; Spudich S
Clin Infect Dis; 2021 Oct; 73(7):e1885-e1892. PubMed ID: 32916708
[TBL] [Abstract][Full Text] [Related]
7. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
[TBL] [Abstract][Full Text] [Related]
8. Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy.
Martínez-Bonet M; Puertas MC; Fortuny C; Ouchi D; Mellado MJ; Rojo P; Noguera-Julian A; Muñoz-Fernández MA; Martinez-Picado J
Clin Infect Dis; 2015 Oct; 61(7):1169-78. PubMed ID: 26063721
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.
Salantes DB; Zheng Y; Mampe F; Srivastava T; Beg S; Lai J; Li JZ; Tressler RL; Koup RA; Hoxie J; Abdel-Mohsen M; Sherrill-Mix S; McCormick K; Overton ET; Bushman FD; Learn GH; Siliciano RF; Siliciano JM; Tebas P; Bar KJ
J Clin Invest; 2018 Jul; 128(7):3102-3115. PubMed ID: 29911997
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Bender Ignacio RA; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N;
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 35544209
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Ignacio RAB; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 34841369
[TBL] [Abstract][Full Text] [Related]
12. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
Pai NP; Lawrence J; Reingold AL; Tulsky JP
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006148. PubMed ID: 16856117
[TBL] [Abstract][Full Text] [Related]
13. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.
Kearney MF; Wiegand A; Shao W; Coffin JM; Mellors JW; Lederman M; Gandhi RT; Keele BF; Li JZ
J Virol; 2016 Feb; 90(3):1369-76. PubMed ID: 26581989
[TBL] [Abstract][Full Text] [Related]
14. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
[TBL] [Abstract][Full Text] [Related]
15. Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.
Strongin Z; Micci L; Fromentin R; Harper J; McBrien J; Ryan E; Shenvi N; Easley K; Chomont N; Silvestri G; Paiardini M
J Virol; 2020 Jul; 94(14):. PubMed ID: 32350073
[TBL] [Abstract][Full Text] [Related]
16. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
Cummins NW; Rizza S; Litzow MR; Hua S; Lee GQ; Einkauf K; Chun TW; Rhame F; Baker JV; Busch MP; Chomont N; Dean PG; Fromentin R; Haase AT; Hampton D; Keating SM; Lada SM; Lee TH; Natesampillai S; Richman DD; Schacker TW; Wietgrefe S; Yu XG; Yao JD; Zeuli J; Lichterfeld M; Badley AD
PLoS Med; 2017 Nov; 14(11):e1002461. PubMed ID: 29182633
[TBL] [Abstract][Full Text] [Related]
17. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.
Buzon MJ; Martin-Gayo E; Pereyra F; Ouyang Z; Sun H; Li JZ; Piovoso M; Shaw A; Dalmau J; Zangger N; Martinez-Picado J; Zurakowski R; Yu XG; Telenti A; Walker BD; Rosenberg ES; Lichterfeld M
J Virol; 2014 Sep; 88(17):10056-65. PubMed ID: 24965451
[TBL] [Abstract][Full Text] [Related]
18. Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption.
Esmaeilzadeh E; Etemad B; Lavine CL; Garneau L; Li Y; Regan J; Wong C; Sharaf R; Connick E; Volberding P; Sagar M; Seaman MS; Li JZ
Sci Transl Med; 2023 May; 15(695):eabq4490. PubMed ID: 37163616
[TBL] [Abstract][Full Text] [Related]
19. Acute HIV-1 infection viremia associate with rebound upon treatment interruption.
Mdluli T; Li Y; Pinyakorn S; Reeves DB; Cardozo-Ojeda EF; Yates A; Intasan J; Tipsuk S; Phanuphak N; Sacdalan C; Colby DJ; Kroon E; Crowell TA; Thomas R; Robb ML; Ananworanich J; de Souza M; Phanuphak P; Stieh DJ; Tomaka FL; Trautmann L; Ake JA; Hsu DC; Francisco LV; Vasan S; Rolland M
Med; 2022 Sep; 3(9):622-635.e3. PubMed ID: 35870446
[TBL] [Abstract][Full Text] [Related]
20. Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
Clarridge KE; Blazkova J; Einkauf K; Petrone M; Refsland EW; Justement JS; Shi V; Huiting ED; Seamon CA; Lee GQ; Yu XG; Moir S; Sneller MC; Lichterfeld M; Chun TW
PLoS Pathog; 2018 Jan; 14(1):e1006792. PubMed ID: 29324842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
